« Back to Team
Chief Business Officer

David Meininger, PhD, MBA


Co-founder and CEO, Link Immunotherapeutics
Chief Business Officer, Trianni
Executive Director, Business Development & Licensing, Merck
Executive Director, Molecular Discovery, Merck
Senior Director, Biologics Discovery, Merck
Vice President, Biotherapeutics, Boehringer Ingelheim

Various roles at Amgen and Genentech

David is the Chief Business Officer at AbTherx. He has over 25 years of biopharma experience and a diverse background that spans startup, midsize, and industry-leading organizations where he has proven himself successful in new company formation, business development, and licensing. Prior to joining AbTherx, David was the Co-founder and CEO of Link Immunotherapeutics. While there, he played an integral role in the company’s formation, successful fundraising, and development of next-generation T-cell engaging therapies. Prior to his time at Link, David was Chief Business Officer at Trianni where he was responsible for defining the company’s growth and partnering activities, including value creation through partnerships with large pharmaceutical and biotech partners. Earlier in his career, David held senior BD&L and biotherapeutic research roles of increasing responsibility at a number of companies, including Merck, Boehringer Ingelheim, Amgen, and Genentech.

David received his PhD from the University of California, San Diego and his MBA from the University of Washington, Michael G. Foster School of Business.